Gabelli Funds LLC grew its holdings in shares of Davita Inc (NYSE:DVA) by 21.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 133,500 shares of the company’s stock after buying an additional 23,500 shares during the period. Gabelli Funds LLC owned 0.08% of Davita worth $6,870,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also made changes to their positions in DVA. Schroder Investment Management Group lifted its holdings in Davita by 102.6% during the 2nd quarter. Schroder Investment Management Group now owns 265,663 shares of the company’s stock worth $18,636,000 after buying an additional 134,558 shares during the last quarter. Denali Advisors LLC lifted its holdings in shares of Davita by 64.4% in the 3rd quarter. Denali Advisors LLC now owns 9,700 shares of the company’s stock valued at $695,000 after purchasing an additional 3,800 shares during the last quarter. Bank of Montreal Can lifted its holdings in shares of Davita by 5.5% in the 3rd quarter. Bank of Montreal Can now owns 257,435 shares of the company’s stock valued at $18,440,000 after purchasing an additional 13,366 shares during the last quarter. Polianta Ltd purchased a new stake in shares of Davita in the 3rd quarter valued at about $1,203,000. Finally, Andra AP fonden lifted its holdings in shares of Davita by 7.4% in the 3rd quarter. Andra AP fonden now owns 126,900 shares of the company’s stock valued at $9,090,000 after purchasing an additional 8,700 shares during the last quarter. 84.66% of the stock is owned by institutional investors.
DVA opened at $56.85 on Wednesday. The company has a quick ratio of 1.82, a current ratio of 1.84 and a debt-to-equity ratio of 2.09. The company has a market cap of $9.44 billion, a price-to-earnings ratio of 17.12, a P/E/G ratio of 0.58 and a beta of 1.31. Davita Inc has a 52 week low of $48.25 and a 52 week high of $79.11.
Davita (NYSE:DVA) last posted its quarterly earnings data on Wednesday, November 7th. The company reported $0.56 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.89 by ($0.33). The company had revenue of $2.85 billion for the quarter, compared to analysts’ expectations of $2.93 billion. Davita had a net margin of 5.39% and a return on equity of 13.87%. The firm’s revenue was up 3.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.81 earnings per share. On average, equities research analysts expect that Davita Inc will post 3.56 earnings per share for the current fiscal year.
Several analysts have recently weighed in on DVA shares. Deutsche Bank started coverage on Davita in a report on Thursday, January 3rd. They issued a “buy” rating and a $60.00 target price for the company. ValuEngine raised Davita from a “hold” rating to a “buy” rating in a report on Tuesday, October 9th. TheStreet downgraded Davita from a “b-” rating to a “c+” rating in a report on Thursday, November 8th. Zacks Investment Research downgraded Davita from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. Finally, Royal Bank of Canada reissued a “hold” rating and issued a $65.00 target price on shares of Davita in a report on Wednesday, January 9th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company’s stock. Davita currently has a consensus rating of “Hold” and an average target price of $71.93.
TRADEMARK VIOLATION NOTICE: “Davita Inc (DVA) Holdings Increased by Gabelli Funds LLC” was published by Enterprise Leader and is the property of of Enterprise Leader. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://theenterpriseleader.com/2019/02/06/davita-inc-dva-holdings-increased-by-gabelli-funds-llc.html.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
See Also: Convertible Shares
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.